MetLife Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Adjusted Earnings: Approximately $1.6 billion, or $2.43 per share, a 15% increase year-over-year; adjusted EPS rose 20%.

Net Income: $705 million, or $1.09 per share.

Adjusted Return on Equity (ROE): 17%, at the top end of the 15%-17% target range.

Direct Expense Ratio: 12.1%, aligned with full-year targets despite a 50 basis point impact from the PineBridge acquisition.

Sales Growth: 7% increase in sales, with strong performance in international markets.

Variable Investment Income: $231 million pretax, higher than the previous year.

2Strategic Updates and Business Highlights

New Frontier Strategy: MetLife's strategy focuses on two earnings engines: capital-light businesses (Group Benefits, Latin America, EMEA, Asset Management) and capital-driven businesses (Retirement and Income Solutions).

Group Benefits: Adjusted earnings of $503 million, up 25% year-over-year, driven by favorable underwriting performance and volume growth.

Retirement and Income Solutions (RIS): Adjusted earnings of $377 million, up 2%, with a 19% increase in adjusted PFOs excluding pension risk transfers.

Asia: Adjusted earnings of $420 million, a 21% increase; sales rose 17% on a constant currency basis.

Latin America: Adjusted earnings of $268 million, a record high, with a 15% increase year-over-year.

MetLife Investment Management (MIM): Adjusted earnings of $57 million, up 6%, with total assets under management reaching approximately $748 billion.

3Forward Guidance and Outlook

Capital Management: MetLife repurchased approximately $700 million of common shares in Q2 and announced a new $3 billion share repurchase authorization.

Growth Expectations: Continued focus on organic growth and disciplined capital allocation, with a target to sustain adjusted earnings growth and return excess capital to shareholders.

Retirement Origination: Anticipated stronger pipeline for pension risk transfers (PRT) in the second half of 2026, despite a lighter first half.

4Bad News, Challenges, or Points of Concern

Mortality Trends: Favorable mortality in Group Life may normalize, potentially impacting future earnings; expectations of moderation in mortality improvements.

Variable Investment Income: Lower private equity returns impacted overall investment income; future returns remain uncertain.

Expense Management: While the direct expense ratio is on target, the integration of PineBridge Investments may pose challenges in maintaining expense efficiency.

PRT Market: The jumbo PRT market has been lighter, and while a stronger pipeline is expected, the lumpiness of this market remains a concern.

5Notable Q&A Insights

M&A Strategy: MetLife remains open to acquisitions in asset management and group benefits but maintains a disciplined approach to capital deployment.

Group Life Pricing: Management indicated that favorable mortality trends may lead to gradual normalization in pricing over time, with no immediate need for adjustments.

Private Equity Positioning: MetLife is trimming its private equity exposure, reflecting a strategic shift in response to higher interest rates and market conditions.

Asia Market Resilience: Despite market volatility in Japan, MetLife's diversified distribution and product innovation are driving sales growth. Overall, MetLife reported a strong quarter with broad-based growth across segments, while also navigating potential challenges in mortality trends and investment income. The company remains focused on executing its strategic initiatives and delivering shareholder value.